Daiwa Securities Group
NERV icon

Daiwa Securities Group’s Minerva Neurosciences NERV Stock Holding History

Daiwa Securities Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27
Closed -$2K – 1231
2019
Q3 		$2K Hold
27
– – ﹤0.01% 1132
2019
Q2 		$1K Hold
27
– – ﹤0.01% 1182
2019
Q1 		$2K Hold
27
– – ﹤0.01% 1137
2018
Q4 		$1K Hold
27
– – ﹤0.01% 1132
2018
Q3 		$3K Hold
27
– – ﹤0.01% 1108
2018
Q2 		$2K Hold
27
– – ﹤0.01% 1142
2018
Q1 		$1K Buy
+27
New +$1.3K ﹤0.01% 1151

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAI
Index Venture Associates IV St. Helier, Channel Islands, Jersey $6.24M AUM
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Daiwa Securities Group's NERV Position: Q4 2019 in Review

Daiwa Securities Group sold out of Minerva Neurosciences (NERV) in Q4 2019, closing a stake of 27 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in NERV in Q1 2018 and held it in 7 quarters. The position peaked at $3K in Q3 2018. 92 funds tracked by Wall St. Rank hold NERV as of Q4 2019.

  • Daiwa Securities Group reported no remaining Minerva Neurosciences position as of Q4 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 27 Minerva Neurosciences shares in Q4 2019, an estimated $2K.
  • Daiwa Securities Group first reported a position in Minerva Neurosciences in Q1 2018 and held it in 7 quarters.
  • Daiwa Securities Group's Minerva Neurosciences position peaked at $3K in Q3 2018.
  • 92 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2019.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.